sodic secondary hypertension along with headaches, sweating, and palpitations [4] [5] [6] . Up to 40% of patients with pheochromocytoma may present with adrenal incidentaloma alone [4] [5] [6] .
If pheochromocytoma is not diagnosed or is left untreated, the excessive secretion of catecholamines may have life-threatening consequences. Therefore, although pheochromocytomas are rare tumors, highly sensitive biochemical tests are needed to discriminate between them and inactive adrenal adenomas. Highly specific biochemical tests are also needed to decrease the false positive rate and to avoid unnecessary evaluations including imaging and surgery. The diagnosis of pheochromocytoma or paraganglioma was histologically confirmed after surgery at our institution (n = 103). The possibility of pheochromocytoma or paraganglioma was excluded when another histologic diagnosis was obtained after surgery or if no evidence of a mass was found upon abdominal CT or MRI and patients for whom the disease was excluded by observing at least 2 years of negative clinical follow up after initial testing (n = 294, control group). In addition, we selected asymptomatic adrenal incidentaloma cases, those with urinary fractionated metanephrines within our institution's reference values, but not surgically confirmed (n = 418). Patients were required to discontinue the use of drugs that might affect results (e.g., tricyclic antidepressants, acetaminophen, labetalol, phenoxybenzamine, caffeine, nicotine, clonidine, ephedrine, calcium channel blockers) in the five days prior to the biochemical testing.
Measurements of fractionated metanephrines were also performed in 49 healthy normotensive volunteers (mean age, 23.8 ± 2.6 years; 25 males and 24 females) who were not taking antidepressants. We included only verified pheochromocytoma patients and control group patients for the statistical analysis of cut-off values and diagnostic efficacy.
Biochemical methods
We measured 24-h urinary metanephrines using an Agilent 1200 HPLC system (Agilent Technologies, Palo Alto, CA, USA) with an ESA Coulochem III electrochemical detector (ESA, Chelmsford, MA, USA). Assay sensitivity was 10 µg/L for both urinary metanephrine and normetanephrine. Assay variability was determined by within-run coefficients of variation of 5.6% for 119 µg/L and 3.2% for 580 µg/L of urinary metanephrine, and 4.1% for 349 µg/L and 4.9% for 1,325 µg/L of urinary normetanephrine. Between-run coefficients of variation were 4.8% for 118 µg/L and 6.2% for 573 µg/L of urinary metanephrine, and 6.5% for 356 µg/L and 7.4% for 1,294 µg/L of urinary normetanephrine. Current reference values used at our institution were based on the 2.5th-97.5th percentiles from 51 healthy volunteers aged over 17 years examined at the Nichols Institute [19] . These values are 45-290 µg/d for metanephrine and 82-500 µg/d for normetanephrine.
The diagnosis of pheochromocytoma and paraganglioma depends on the overproduction of catecholamines [7, 8] . Because pheochromocytomas may secrete catecholamine intermittently or in low amounts, diagnosis should involve a combination of tests including measurements of metanephrines, the O-methylated metabolites of catecholamines [9, 10] . The measurement of urinary metanephrines originally involved a spectrometric assay for metanephrine and normetanephrine measured as a single analyte, termed "total metanephrines." Now, these assays for total urinary metanephrines have been superseded by high-performance liquid chromatography (HPLC) assays that allow the separate measurement of metanephrine and normetanephrine, termed "fractionated metanephrines" [11] .
Several recent reports have suggested that the measurement of plasma-fractionated metanephrine has a high sensitivity for the detection of disease [12] [13] [14] . However, such measurements also show relatively high false positive test results [13] and are therefore recommended only when the index of clinical suspicion is high. In Korea, the measurement of plasma metanephrine had not been available until now.
To avoid false positives, diagnostic cut-off values of 900 µg/d for urinary normetanephrine and 400 µg/d for urinary metanephrine were determined to distinguish non-pheochromocytoma-hypertensive patients from pheochromocytoma-positive patients [15, 16] . These values are more than twice the normal upper limit. In addition, Perry et al. reported metanephrine and normetanephrine diagnostic cut-off values for pheochromocytoma of 302 µg/d and 733 µg/d, respectively, as measured by tandem mass spectrometry [17] . However, there are limited data to suggest optimal cut-off values in Asian patients, and whether different cut-off values are necessary according to sex has not been evaluated [18] . Here, we aimed to establish cut-off values for urinary fractionated metanephrines for the diagnosis of pheochromocytoma in Korean patients and to determine cut-off values according to sex.
Methods

Subjects
We reviewed the medical records of patients whose 24-h fractionated metanephrines were measured using HPLC and adrenal imaging by abdominal computed tomography (CT) or magnetic resonance imaging (MRI) at Samsung Medical Center (a tertiary referral pheochromocytoma was present in 87.4% of the pheochromocytoma or paraganglioma patients (90/103) .
Among the 397 patients (103 with pheochromocytoma and 294 from the control group), the reasons for biochemical testing were investigation for secondary hypertension or typical symptoms in 223 (56.2%), asymptomatic adrenal mass in 94 (23.7%), hypertension and adrenal mass in 48 (12.1%), suspected genetic syndrome in 26 (6.5%), and suspected recurrence in 6 (1.5%). Twenty six patients suspected of genetic syndrome underwent genetic testing and seven patients had von Hippel-Lindau's diseases (four pheochromocytoma patients and three patients in the control group), one patient was MEN II and one patient was MEN I, confirmed by identification of VHL, RET and MEN I mutations. The controls consist of three patients groups. The first group included 210 patients with suggestive symptoms or hypertension, but the disease was excluded by negative imaging test and observed at least 2 years of follow up. (mean: 4.9±1.7 years, range: 2-8.2 years). The second group consisted of 63 patients who were investigated for adrenal incidentaloma and the disease was excluded after surgery. Among these 63 patients, 15 had adrenal adenoma, 10 had adrenal carcinoma and remaining 38 had ganglioneuroma, angiomyolipoma or other tumors. The last group included 21 patients undergoing test for familial syndrome (one MEN II and three von Hippel-Lindau's disease).
We found significant differences in metanephrine and normetanephrine levels between male subjects and female subjects both in the healthy volunteer group and the control group ( Table 2) . The healthy volunteers' upper limit values were as follows: metanephrine, 225 µg/d for males and 193 µg/d for females; normetanephrine, 356 µg/d for males and 237 µg/d for females. These values were lower than the normal upper reference values used at our institution, which were based on 51 healthy individuals of European descent (metanephrine, 290 µg/d; normetanephrine, 500 µg/d). The control group's upper limit values were as follows: metanephrine, 307.8 µg/d for males and 182.9 µg/d for females; normetanephrine, 600 µg/d for males and 558 µg/d for females ( Table 2) .
Establishment of cut-off values and diagnostic efficacy for fractionated metanephrines
ROC curves were used to determine cut-off values for both males and females. The cut-off values for metanephrine were 229.5 µg/d in males and 174 µg/d in
Statistics
Descriptive analyses were performed using the medians and ranges for continuous variables and percentages for categorical variables. Urinary metanephrine and normetanephrine were expressed as their median values and ranges. The Mann-Whitney test was used to compare the median values of fractionated metanephrines. Receiver operating characteristic (ROC) curves were used to determine cut-off values that have the maximal sum of sensitivity and specificity. Because we assumed that cut-off values might differ according to sex, we first determined cut-off values according to sex and then determined them without considering sex.
Sensitivity was calculated from the positive test results of patients with pheochromocytoma or paraganglioma. Specificity was calculated from the negative test results of patients without pheochromocytoma or paraganglioma. Correlations between fractionated metanephrines level and variables including body weight, body surface area, blood pressure were calculated using Spearman's correlation test. Multivariate linear regression analysis using a general linear model was performed to evaluate the factors associated with fractionated metanephrines level, including age, sex, body weight, body surface and blood pressure. A p-value<0.05 was considered significant. Statistical analyses were performed with the SPSS 18.0 software package (SPSS, Inc., Chicago, IL, USA).
Results
Patient characteristics
We analyzed 103 patients with pheochromocytoma or paraganglioma and 294 patients without pheochromocytoma or paraganglioma. Of the patients with pheochromocytoma, 49.5% were males and the mean age at testing was 50.9 ± 14.9 years (Table 1) . Adrenal (Table 3) .
Next, we determined cut-off values without considering sex differences and evaluated the diagnostic efficacy (Table 4 ). The cut-off value for metanephrine was 174 μg/d and the cut-off value for normetanephrine was 485.5 μg/d. When we applied cut-off values without considering sex, the specificity of the metanephrine fraction decreased to 80.4% and that of the normetanephrine fraction decreased to 91.1% in male subjects. The sensitivity of the metanephrine fraction decreased to 80.4%. When the positive test was defined as either metanephrine or normetanephrine levels above the cutoff values, the specificity was decreased to 77.8% in male subjects (Table 4) .
The areas under the curves (AUCs) were as follows: metanephrine fraction, 0.858 (0.807-0.908); normetanephrine, 0.955 (0.932-0.978); either metanephrine or normetanephrine positive, 0.981 (0.968-0.994) (p < 0.001 for all of these areas in comparison to a reference line with an AUC of 0.5; Fig. 1 ). females, and those for normetanephrine were 502 µg/d for males and 471 µg/d for females (Table 3) . These values in females were much lower than the upper reference values used by our institution, which were based on healthy individuals of European descent (metanephrine: 290 µg/d; normetanephrine: 500 µg/d).
We analyzed the diagnostic efficacy of fractionated metanephrine according to sex. In male subjects, the metanephrine fraction sensitivity and specificity were 74.5% and 94.3%, respectively; the normetanephrine fraction sensitivity and specificity were 86.3% and 93%, respectively. In female subjects, the metanephrine fraction sensitivity and specificity were 65.4% and 97.8%, respectively; the normetanephrine fraction sensitivity and specificity were 86.5% and 95.6%, respectively. When considering the combination of a positive metanephrine fraction with a normetanephrine fraction, the sensitivity increased to 96% and the specificity decreased to 88.6% in male subjects, while the sensitivity increased to 98.1% and the specificity decreased Correlation between body weight, body surface area, blood pressure and fractionated metanephrines in the control group Body weight, height and blood pressure were measured in 246 subjects in the control groups. The mean body weight (kg) was 59.5 ± 1.03 in females and 73 ± 0.94 in males (p < 0.001), the mean height (cm) was 157.1 ± 0.77 in females and 171.1 ± 0.65 in males, and the mean body surface area (m 2 ) was 1.57 ± 0.01 in females and 1.84 ± 0.01 in males (p < 0.001). We detected a weak positive correlation between body weight and metanephrine level (r = 0.11, p = 0.02), and between body weight and normetanephrine level (r = 0.21, p = 0.007). There was also a weak but significant correlation between body surface area and metanephrine level (r = 0.15, p = 0.01) and between body surface area and normetanephrine level (r = 0.17, p = 0.001). Systolic blood pressure was significantly correlated with normetanephrine level (r = 0.23, p < 0.001).
Multivariate linear regression analysis was performed to evaluate the factors associated with fractionated metanephrines level. There was significant correlation between sex and metanephrine level (p = 0.011) and systolic blood pressure and normetanephrine level (p = 0.03) on linear regression analysis (Table 5) .
Correlation between tumor size and urinary fractionated metanephrines
There was a weak positive correlation between the pheochromocytoma tumor size and urinary normetanephrine level (r = 0.44, p < 0.001), but there was no significant correlation between tumor size and urinary metanephrine level (r = 0.09, p = 0.38). area as well as fractionated metanephrine and body weight. In addition, the difference in metanephrine and normetanephrine levels between men and women in this study may be associated with differences in body size between men and women. Lenders et al. also used different cut-off values in male and female subjects [12] . Therefore, we assumed that lower cut-off values for urinary metanephrines in Korean subjects, especially in women, could be explained by their lower body weight and lower body surface area compared to subjects of European descent. We also performed multivariate regression analysis to evaluate the independent effects of factors on fractionated metanephrines level including age, sex, body weight, body surface area and blood pressure. There was significant correlation between sex and metanephrine level and systolic blood pressure and normetanephrine level. When we performed ROC analysis according to presence of hypertension, optimal cut off values of normetanephrine was different between patients with HTN and patients without HTN (571 μg/day vs. 480 μg/day). However, there was no improvement of diagnostic sensitivity and specificity, when we applied cut-off values according to hypertension. The sensitivity was significantly decreased from 98% to 92.2% and specificity was slightly decreased from 85.4% to 85%, compared to without considering presence of hypertension (data not shown). Therefore, we thought that different cutoff value of normetanephrine according to presence of hypertension was not clinically useful to improve the diagnostic efficacy.
Adrenal incidentaloma frequently includes asymptomatic pheochromocytoma [5, 6] . In a Korean survey of 132 adrenal incidentaloma patients, 12 were found to have pheochromocytomas [20] . Of our 103 pheochromocytoma cases, 33 (32%) were incidentally diagnosed as asymptomatic adrenal tumors. The detection rate for adrenal incidentaloma in Korea has been increasing, [20] suggesting that effective hormonal screening is needed for assessing incidentaloma. Despite the lower cut-off values for Koreans compared to those of European descent, urinary fractionated metanephrines had a high level of sensitivity and specificity in our study, when we applied our cutoff values, and our findings were similar to those in previous reports [12, 17] .
We note that our study has some limitations. First, the present study design was retrospective, follow up
Analysis of adrenal incidentaloma
Upon analysis of adrenal incidentaloma, not confirmed histologically (n = 418), 17 patients (16 females and 1 male) showed higher values of fractionated metanephrines above our newly defined cut-off level. These patients needed to be re-evaluated, but unfortunately only 2 of the 17 patients have currently undergone follow-up, and repeated tests showed levels below our cut-off level.
Discussion
In this study, we investigated the diagnostic efficacy of urinary fractionated metanephrine and determined cut-off values in Korean subjects according to sex. When we applied our cut-off values considering sex, the diagnostic sensitivity was 96% and specificity was 88.6% in male subjects and the sensitivity and specificity were 98.1% and 94.1%, respectively, in female subjects for the diagnosis of pheochromocytoma (defining a positive test as either a metanephrine or normetanephrine level above the cut-off values). However, when we applied cut-off values without considering sex, the specificity decreased from 88.6% to 77.8% in male subjects.
The diagnosis of pheochromocytoma is crucial based on the documented possibility of excessive catecholamine secretion [12] . Accumulating evidence strongly indicates that the measurement of metanephrines in plasma and urine offers significant advantages over the measurement of catecholamines in the diagnosis of these tumours [12] [13] [14] .
The currently used cut-off values for metanephrines were determined based on a two-fold elevation above the upper limit found in normal volunteers in order to avoid an excessive false positive rate [15, 16] . Recently, Perry et al. found that diagnostic cut-off values for metanephrine and normetanephrine were 51% and 71% higher than those in normal volunteers [17] .
In our analysis, we defined cut-off values for metanephrine and normetanephrine based on ROC curves. The cut-off value for metanephrine was not significantly different than the normal healthy volunteers' upper limit value. However, the cut-off value of normetanephrine was 40% higher in males and 90% higher in females than the normal volunteers' upper limit value.
In our analysis of 246 control group subjects, we found a weak yet statistically significant relationship between fractionated metanephrine and body surface the reference range used at our institution, which is based on 51 healthy individuals of European descent. These differences could be explained by differences in the glomerular filtration rates between races and sexes. Our findings emphasize the importance of establishing local reference values and considering sex differences. Further studies need to be confirmed in other eastern Asian countries.
